Atypical fast-growing Mycobacterium species are usually identified after laser-assisted in situ keratomileusis, cosmetic surgeries, and catheter-related, pulmonary or soft tissue infections.
Introduction
Ocular tuberculosis (TB) is a complex clinical entity that presents diagnostic and management challenges for both ophthalmologists and infectious disease specialists, as well as for public health workers. Depending on its clinical manifestations, ocular TB can involve intraocular or extraocular tissues and structures. Intraocular TB is more common than the extraocular form, 1 and its diagnosis is more complicated. 2 Interstitial keratitis, which indicates the spread of infection to the corneal stroma, is one of the miscellaneous presentations of extraocular TB. Scleritis (necrotizing or non-necrotizing) can also occur simultaneously. 3 Mycobacterium aurum is a Gram-positive, acid-fast bacterium which is fast-growing and mostly non-infectious. 4 It belongs to the atypical category of mycobacteria that do not cause TB or Hansen's disease. This species, also called non-tuberculous mycobacteria (NTM), is also known as environmental mycobacteria or mycobacteria other than tuberculosis-causing. In contrast to typical TB infections, this atypical mycobacterial infection is non-communicable. The species is present in the environment, especially in wet soils, rivers, lakes, and swamps. Rapidly growing mycobacteria other than M. aurum include Mycobacterium fortuitum, Mycobacterium chelonae, Mycobacterium abscessus and Mycobacterium neoaurum. Except for M. aurum, which is usually commensal, other species are pathogenic in humans, and can cause cellulitis, osteomyelitis, wound infections, and central catheter-related infections. 5, 6 Non-tuberculous mycobacterial keratitis was first reported by Turner and Stinson in 1965. 7 Since then, the number of cases recorded has increased. In 2002, there was an outbreak of M. chelonae keratitis associated with laser-assisted in situ keratomileusis. Further research showed that this type of surgery could be a risk factor for the development of NTM keratitis. 8 Despite the increase in the number of documented cases since the first description in 1965, NTM keratitis continues to pose challenges in terms of diagnosis and management.
To the best of our knowledge, this is the first documented case of keratitis caused by the NTM M. aurum. The bacterium was responsible for keratitis as well as the troublesomely silent extra-ocular progression of the disease in the absence of general signs or symptoms.
The Institutional Review Board and the Ethics Committee of Shiraz University of Medical Sciences approved the decision to report this novel case. The patient also gave his written informed consent.
Case presentation
The patient was a 56-year-old man who presented with a chief complaint of left eye redness, foreign body sensation and tearing. Based on an initial diagnosis of viral conjunctivitis, a topical corticosteroid was prescribed. One month later, the patient returned with aggravated symptoms and purulent discharge, eyelid swelling, photophobia, and corneal infiltration. He was diagnosed as having secondary bacterial keratitis and was treated with moxifloxacin and sulfacetamide. In the course of follow-up, during the subsequent two months, the cornea did not heal and the patient developed progressively blurred vision.
At this time a confocal scan was negative for fungal or acanthamoeba infection. Superficial keratectomy was done for diagnostic and therapeutic purposes. The pathology and microbiology reports were negative. The complete preoperative laboratory work-up included complete blood cell count, fasting blood sugar, blood urea nitrogen, serum creatinine, sodium, potassium, phosphate, and calcium, liver function tests, lipid profiles, urinalysis, and stool analysis for occult blood, ova, and parasites. All results were normal except for an elevated lymphocyte count (45.8% whole blood cells, equivalent to 4000/µL) slightly elevated uric acid (8.9 mg/dL), and low-density lipoprotein (133 mg/dL). Blood cultures were performed with blood samples from three different sites, but no organisms grew. Plain chest X-ray revealed no abnormal findings.
Because of worsening infective keratitis and invasion of deeper layers of the cornea (Fig. 1A) , a conjunctival flap procedure was done. However, after one month the flap became necrotic and retracted, and was therefore debrided. A second corneal biopsy was obtained, and this time the pathology report indicated mycobacterial keratitis with positive acid-fast staining. As a result of this diagnosis, topical and oral moxifloxacin and azithromycin were started. However, because the infection progressed and early corneal melting appeared, we decided to perform corneal collagen cross-linking (CXL) with riboflavin and ultraviolet light. Curative CXL was done with two major goals: to stop and resolve the infective process, and to slow corneal melting. After 1-2 weeks we observed partial resolution of the infection. However, due to progression of the residual infection and dense opacification of the cornea, we decided to perform corneal graft transplantation with the penetrating keratoplasty method.
A final biopsy of the excised cornea was sent to the national TB reference center in Tehran, Iran for polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay, which confirmed M. aurum as the causal agent. Throughout the course of the infection, the patient was afebrile and physical examination was normal. At the time of writing, the patient is well (Fig. 1B) with satisfactory slit lamp findings, and a single-eye visual acuity of 20/400. 
Identification of non-tuberculosis mycobacteria by PCR-RFLP
The mycobacterial species was identified by molecular methods. DNA was extracted from the eye biopsy sample with a standard method. 9 Briefly, 1 mL of decontaminated sample was heat-killed at 90°C for 30 min. The sample was lysed in digestion buffer (500 mM Tris-HCl, pH 9.0, 20 mM EDTA, 10 mM NaCl, 1% SDS). The DNA was purified by phenol and chloroform/isoamyl alcohol (24:1 vol/vol) and was precipitated by isopropanol. The pellet was washed in 70% ethanol and dried at room temperature. It was then resuspended in TE buffer (50 mM Tris, 100 mM EDTA, Fig. 2) .
Discussion
Mycobacterium aurum was first described by Tsukamura in 1996. 11 Since then, only three cases of infection by this type of Mycobacterium have been published. The first one (1998) was a 60-year-old man being treated for T-cell non-Hodgkin's lymphoma. He presented with fever, chills and weight loss of three weeks' duration, and catheter-related bacteraemia by M. aurum was found to be responsible. 12 The second one In the two previous cases, M. aurum was found in blood cultures, but in the last case blood cultures were negative and M. aurum was detected by solid-organ lung biopsy. 13 
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The bacterium can be identified via two methods: biochemical analysis and molecular-based methods. The first, which is conventionally used, depends on the diagnosis and isolation of mycobacteria and subsequent phenotypic or whole-cell fatty acid analysis. Molecular-based analysis is the gold standard method, particularly in unidentified cases. 14 Gene sequencing is the best molecular-based method, which in some cases leads to reclassification of previously diagnosed M. aurum to other mycobacterial species. 15, 16 But PRA (PCR-RFLP Analysis) method is also one of the most reliable techniques, especially for identification of mycobacterial species, and its efficacy has been well-established and well-proven. [17] [18] [19] [20] [21] We used this method by means of 65-kDa heat shock protein on two samples and both results definitively confirmed the presence of M. aurum.
In comparison to previous cases, our patient's general condition was good and no signs or symptoms were detected, even on chest X-ray. He was not immunocompromised in any way, but was well and had no underlying disease (including diabetes or malignancy). He was not taking immunosuppressants, and did not have an arterial or venous catheter. The only factor that may have made our patient prone to this infection was occupational exposure, since the air at his workplace contained large amounts of dust and soil particles in suspension. The patient also mentioned a minor trauma to his eye.
Infection by M. aurum is a potential threat in the management of critical cases of ocular TB even in patients with no predisposing factors. Early diagnosis and prompt treatment may be sight-saving. We suggest considering NTM among the probable causes of complicated keratitis, and as a possible cause in patients who fail to respond to drug treatment, especially in regions where TB is endemic. 22, 23 We also recommend additional laboratory tests when the type of Mycobacterium remains unidentified.
